ad image

Regulatory Compliance

1 / 1
Wheeler Bio
Business Leadership

Wheeler Bio Appoints Marc Helouin as Chief Quality and Regulatory Officer

Wheeler Bio

PR-M08-23-01Aug 15, 2023
Preparing Today for a Potential Ban on Titanium Dioxide in Pharmaceutical Drug Products
Alternative Excipient

Preparing Today for a Potential Ban on Titanium Dioxide in Pharmaceutical Drug Products

Almut von der Brelie

MilliporeSigma

PAO-08-23-CL-01Aug 03, 2023
Does Your Biologics CDMO Truly Have a Culture of Quality?
Quality Culture

Does Your Biologics CDMO Truly Have a Culture of Quality?

Joe Payne

Scorpius BioManufacturing

PAO-07-23-CL-07Jul 27, 2023
Staying Ahead of the Curve with Outsourced Program Management
Pharmaceutical Consultancy

Staying Ahead of the Curve with Outsourced Program Management

PharmaLex

PAO-02-23-PATV-01Feb 07, 2023
Controlled Substances in Clinical Trials: Considerations, Challenges, and Growing Demand
Controlled Substances in Clinical Trials

Controlled Substances in Clinical Trials: Considerations, Challenges, and Growing Demand

Rich Nelson; John Hufnagel; Rachel Castro

PCI Pharma Services

PAO-01-23-CL-03Jan 30, 2023
Overcoming the Challenges of an Ever-changing Biopharma Landscape

Overcoming the Challenges of an Ever-changing Biopharma Landscape

Integrity

PAO-01-23-PATV-01Jan 24, 2023
Cloud Control: Maintaining Compliance as Regulated Apps Move Off Premise
Cloud Regulatory Compliance

Cloud Control: Maintaining Compliance as Regulated Apps Move Off Premise

Thierry Dietrich, Ph.D.

PAO-07-022-CL-08Jul 19, 2022
Rephine
Audit Service Merger

Merger of Rephine with Forum Auditorias & TDV Creates Clear Market Leader in Global GMP Audit Services

Rephine

PR-M07-22-01Jul 06, 2022
ProductLife Group
M&A

ProductLife Group Strengthens Foothold in Northern Europe with Pharma IT Acquisition

ProductLife Group

PR-M06-22-08Jun 30, 2022
The Bioanalytical Development Journey
Bioanalytics

The Bioanalytical Development Journey

Nick Raja, Ph.D.

Scorpius BioManufacturing

PAO-05-022-CL-03May 09, 2022
CAPA Management is Worth Doing, and Worth Doing Well
CAPA Management

CAPA Management is Worth Doing, and Worth Doing Well

Helen Lowe

PAO-04-022-CL-11May 04, 2022
Addressing Regulatory Challenges for Ophthalmic Combination Products
Regulatory Compliance

Addressing Regulatory Challenges for Ophthalmic Combination Products

Jeff Tremain; Ania VanDyke

AbbVie Contract Manufacturing

PAO-04-022-CL-09Apr 28, 2022
Leveraging Broad Capabilities in the Growing Animal Health Market
Animal Health

Leveraging Broad Capabilities in the Growing Animal Health Market

TriRx Pharmaceutical Services

PAO-02-22-R250-09Feb 11, 2022
A Personalized Cell Therapy Chain Management Platform
Cell Therapies

A Personalized Cell Therapy Chain Management Platform

Matthew Lakelin

TrakCel

PAP-Q2-20-CL-032Jul 01, 2020
1 / 1